-
US Food and Drug Administration sued over Ruzurgi drug approval
europeanpharmaceuticalreview
June 20, 2019
Catalyst Pharmaceuticals Inc has sued the FDA to challenge the recent approval of a lower-cost rival drug.
-
MHRA issues recall of paracetamol tablets
europeanpharmaceuticalreview
June 20, 2019
A drug alert has been issued for two batches of paracetamol tablets found to have discolourations due to fungi.
-
Drug Makers Challenge New Rule Requiring Drug Prices in TV Ads
drugs
June 18, 2019
Drug Makers Challenge New Rule Requiring Drug Prices in TV Ads.
-
Drug- and Alcohol-Related Deaths Higher After Bariatric Surgery
drugs
June 17, 2019
Drug- and Alcohol-Related Deaths Higher After Bariatric Surgery.
-
Sobi to acquire emapalumab drug from Novimmune
americanpharmaceuticalreview
June 14, 2019
Swedish Orphan Biovitrum (Sobi) has agreed to buy a newly established firm from Novimmune for a consideration of SEK4,897m ($517.9m).
-
FDA dermatology advisors found to accept payments after drug approvals
europeanpharmaceuticalreview
June 14, 2019
A study has shown that the majority of dermatology advisors to the FDA took payments subsequent to drug approvals.
-
Drug ODs, Suicides Soaring Among Millennials: Report
drugs
June 14, 2019
Drug ODs, Suicides Soaring Among Millennials.
-
Epilepsy Drug Pregabalin (Lyrica) Tied to Higher Risk of Suicidal Behavior in Young Users
drugs
June 14, 2019
Epilepsy Drug Pregabalin (Lyrica) Tied to Higher Risk of Suicidal Behavior in Young Users.
-
Drug, Alcohol, and Suicide Deaths Up Among Millennials
drugs
June 14, 2019
Drug, alcohol, and suicide deaths have increased among millennials, according to a report issued by the Trust for America's Health and the Well Being Trust.
-
Bolder BioTechnology Announces FDA Orphan Drug Designation for BBT-059
americanpharmaceuticalreview
June 13, 2019
Bolder BioTechnology announced its long-acting IL-11 analog, BBT-059, has received Orphan Drug designation from the Food and Drug Administration for treatment of Acute Radiation Syndrome (ARS).